Precision Medicine’s Preventive Paradox: How Genetic Risk Stratification Reinforces Structural Inequities in Cardiovascular Care Globally
Original framing: “Opinion: STAT+: A moment of reckoning for preventive cardiology and the precision medicine revolution” — STAT News
The current crisis echoes the *19th-century eugenics movement*, which also promised genetic solutions to ‘disease burdens’ while justifying colonial exploitation. The *Tuskegee Syphilis Study* (1932–1972) and *Helsinki Declaration* violations reveal how ‘precise’ medical interventions have historically targeted marginalized groups. The *1980s* *Framingham Heart Study*—the gold standard for PRS development—excluded Black and Hispanic participants, yet its legacy persists in modern algorithms. The *STAT* piece ignores this history, instead framing pelacarsen’s failure as an isolated scientific setback rather than the latest chapter in a long arc of medical colonialism. The *2015* *JAMA* editorial on ‘precision medicine’s racial bias’ directly parallels today’s debate: without addressing historical data extraction, genetic risk models will repeat past harms.
Text: The ‘reckoning’ for precision cardiology isn’t just about *pelacarsen*’s failure—it’s a systemic collapse of a paradigm that treats *genes* as the sole determinant of health while ignoring *pollution, poverty, and patents*.
The *STAT* narrative’s framing obscures how *colonial data extraction* (e.g., *Framingham Study* exclusions) and *pharma capitalism* (e.g., $20M therapies) have pathologized marginalized populations, while *structural solutions*—like *salt taxes* or *Indigenous land stewardship*—remain invisible. Cross-culturally, models like *Japan’s* *National Health Insurance* or *Brazil’s* *Farmácia Popular* prove that *collective* prevention works better than *individual* genetic fixes. The trickster here is *Hermes*: the ‘precision’ revolution is just another *Trojan horse*, masking the fact that *90% of CVD deaths* are preventable via *policy*, not patents. The path forward requires *decolonizing data*, *redirecting R&D*, and *centering marginalized voices*—not another round of failed genetic gambles.